Antimalarial mass drug administration: Ethical considerations

International Health

Volumn 8, Issue 4, 2016, Pages 235-238

  Cheah, Phaik Yeong ^a,b,c   White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antimalarials; Elimination; Ethics; Malaria; Mass drug administration; Public health

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE;

DISEASE ELIMINATION; DRUG ADMINISTRATION; DRUG SAFETY; HUMAN; INCIDENCE; MALARIA; MALARIA FALCIPARUM; MASS DRUG ADMINISTRATION; MEDICAL ETHICS; PARASITE PREVALENCE; PATIENT AUTONOMY; PATIENT PARTICIPATION; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; CHEMOPROPHYLAXIS; DISEASE ERADICATION; DRUG RESISTANCE; ENDEMIC DISEASES; ETHICS; MALARIA, FALCIPARUM; PREVALENCE; PROCEDURES; TROPICAL MEDICINE;

ANTIMALARIALS; CHEMOPREVENTION; DISEASE ERADICATION; DRUG RESISTANCE; ENDEMIC DISEASES; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; PREVALENCE; TROPICAL MEDICINE;

EID: 84988872671     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/ihw027     Document Type: Review

References (18)

1. O'Neill O. Informed consent and public health. Philos Trans R Soc Lond B Biol Sci 2004;359:1133-6
2. Upshur RE. Principles for the justification of public health intervention. Can J Public Health 2002;93:101-3
3. Dawson A. What are the moral obligations of the traveller in relation to vaccination? Travel Med Infect Dis 2007;5:90-6
4. WHO. World Malaria Report. Geneva: World Health Organization; 2014
5. Murray CJ, Ortblad KF, Guinovart C et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:1005-70
6. Dondorp AM, Nosten F, Yi P et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-67
7. Ashley EA, Dhorda M, Fairhurst RM et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014;371: 411-23
8. Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol 2008;24:127-34
9. Tanner M, Greenwood B, Whitty CJ et al. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med 2015;13:167
10. Poirot E, Skarbinski J, Sinclair D et al. Mass drug administration for malaria. The Cochrane Database Sys Rev 2013;12:CD008846
11. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther 2015;13:715-30
12. WHO. Malaria Policy Advisory Committee and Secretariate. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015). Malar J 2016;15:117
13. Jamrozik E, de la Fuente-Nunez V, Reis A et al. Ethical aspects of malaria control and research. Malar J 2015;14:518
14. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015
15. White NJ, Pongtavornpinyo W, Maude RJ et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J 2009;8:253
16. Newby G, Hwang J, Koita K et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 2015;93:125-34
17. Selgelid MJ. Ethics and drug resistance. Bioethics 2007;21:218-29
18. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop 2010;114:177-83